Related Experiment Videos
Recognizing genetic hemochromatosis
1Tulane University School of Medicine program in Community Medicine, News Orleans, LA 70112.
Insights
Hemochromatosis is a common genetic disorder causing excess iron buildup. Early detection and phlebotomy therapy can prevent severe complications and ensure a normal lifespan.
Area of Science:
- Genetics
- Internal Medicine
- Gastroenterology
Background:
- Hemochromatosis is a prevalent autosomal recessive genetic disorder.
- It results from excessive intestinal iron absorption and subsequent iron deposition in tissues.
- Affects 3% of Anglo-Saxon descent, typically presenting in males in their 40s and later in females.
Purpose of the Study:
- To review the disease process of hemochromatosis.
- To highlight the importance of early recognition and management.
- To discuss screening recommendations and therapeutic interventions.
Main Methods:
- Literature review of hemochromatosis.
- Analysis of disease presentation, symptoms, and complications.
- Evaluation of screening strategies and treatment efficacy.
Main Results:
- Early symptoms include weakness, lassitude, weight loss, and diabetes mellitus onset.
- The classical triad of cirrhosis, diabetes, and skin pigmentation appears late.
- Early phlebotomy therapy can prevent long-term complications like cirrhosis and hepatoma.
Conclusions:
- Physicians must recognize early signs of hemochromatosis for timely intervention.
- Screening at-risk family members upon identification of a case is recommended.
- Early treatment allows patients a normal lifespan with minimal medical intervention.
Abstract:
This article reviews the disease process hemochromatosis, which is now recognized as one of the most common genetic disorders. Hemochromatosis is transmitted as autosomal recessive, and occurs in 3% of persons of Anglo-Saxon descent. It is caused by an inappropriate increase in intestinal iron absorption resulting in deposition of excess iron in tissues. Hemochromatosis usually presents in males in their 40s, and females much later. The most frequent initial symptoms are weakness, lassitude, weight loss, and symptoms related to the onset of diabetes mellitus. The classical triad of cirrhosis, diabetes mellitus, and skin pigmentation occurs late in the disease. There is debate over the value of mass screening for the disorder; however, it is recommended that once a case has been identified family members at risk should be screened. Therapy is directed at removing excess iron by phlebotomy. By instituting early therapy, many of the long-term complications, including cirrhosis and hepatoma, can be prevented. It is imperative that physicians learn to recognize early signs and symptoms of hemochromatosis so that treated patients can expect a normal life span with minimal medical intervention.